Tetrabenazine

Tetrabenazine
Trade Name
Orphan Indication Moderate/severe tardive dyskinesia
USA Market Approval USA
USA Designation Date 1998-05-12 00:00:00
Sponsor Prestwick Pharmaceuticals, Inc.;1825 K Street, NW, Suite 1475;Washington, District of Columbia, 20006